Secondary Prevention in STEMI Patients: Insights from a Regional Virtual STEMI Clinic

Mina Garas1,2, Paul Mundra1, Brian McGrath1

  • 1McMaster University, Department of Medicine, Hamilton, Ontario, Canada.

CJC Open
|March 2, 2026
PubMed

Insights

A virtual STEMI clinic improved secondary prevention for heart attack patients post-discharge. This program identified and addressed critical gaps in care, optimizing treatment and follow-up for better patient outcomes.

Area of Science:

  • Cardiology
  • Public Health
  • Digital Health

Background:

  • Canadian ST-elevation myocardial infarction (STEMI) care often uses a hub-and-spoke model with early repatriation and rapid discharge.
  • This model may lead to suboptimal secondary prevention in the crucial post-discharge period.
  • A regional virtual STEMI clinic (VSC) was implemented to address these care gaps.

Purpose of the Study:

  • To implement and evaluate a regional virtual STEMI clinic (VSC).
  • To identify and address gaps in secondary prevention for STEMI patients post-discharge.
  • To analyze factors associated with the need for secondary prevention interventions.

Main Methods:

  • Standardized virtual follow-ups were conducted for STEMI patients at a tertiary hospital hub.
  • Data on patient characteristics and secondary prevention interventions were collected.
  • Poisson regression analysis identified factors associated with requiring interventions.

Main Results:

  • The VSC followed 586 STEMI patients (74.6% of total) within a median of 3.9 weeks post-discharge.
  • Significant issues identified included inadequate glucose control in 62.2% of diabetics and suboptimal lipid status in 19.9% of patients.
  • 73.1% of patients received interventions, including medication adjustments, bloodwork, and cardiac rehabilitation referrals.

Conclusions:

  • A structured VSC facilitates timely post-STEMI follow-up.
  • The VSC effectively identified and addressed critical secondary prevention gaps.
  • Interventions included lifestyle modification support, medication optimization, and appropriate follow-up care.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
349
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
347
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
776
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
563
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.7K